Exp Clin Endocrinol Diabetes 2020; 128(02): 77-81
DOI: 10.1055/s-0044-100376
Article
© Georg Thieme Verlag KG Stuttgart · New York

The Variation of Disulfides in the Progression of Type 2 Diabetes Mellitus

Merve Ergin
1   Department of Biochemistry, 25 Aralik State Hospital, Gaziantep, Turkey
,
Cevdet Aydin
2   Department of Endocrinology and Metabolism, Yildirim Beyazit University, Faculty of Medicine, Ankara, Turkey
,
Emine Feyza Yurt
3   Department of Biochemistry, Yildirim Beyazit University, Faculty of Medicine, Ankara, Turkey
,
Bekir Cakir
2   Department of Endocrinology and Metabolism, Yildirim Beyazit University, Faculty of Medicine, Ankara, Turkey
,
Ozcan Erel
3   Department of Biochemistry, Yildirim Beyazit University, Faculty of Medicine, Ankara, Turkey
› Author Affiliations
Further Information

Publication History

received 05 August 2017
revised 25 December 2017

accepted 08 January 2018

Publication Date:
29 January 2018 (online)

Abstract

Aim The purpose of this study was to examine thiol-disulfide balance in patients with type 2 diabetes mellitus.

Methods This study included 32 subjects with known type 2 diabetes mellitus without complications, 30 patients with type 2 diabetes mellitus with complications, 28 newly diagnosed patients with type 2 diabetes mellitus, and 45 healthy individuals. Thiol-disulfide profile tests were quantified in all groups.

Results Compared to the control group, patients in each of the diabetic groups had significantly lower native and total thiol levels, higher disulfide levels, and higher disulfide/native thiol and disulfide/total thiol ratios (p<0.05 for all). Disulfide levels were significantly lower in the newly diagnosed group than in other diabetic groups (p<0.05). There were significant associations between glycemic parameters and thiol-disulfide tests (p<0.05).

Conclusions A disequilibrium between thiol-disulfide pairs occurs in patients with type 2 diabetes mellitus, and a gradual increase to disulfide levels may contribute to the disease’s severity. Deteriorated thiol-disulfide homeostasis may be relevant to the pathophysiology of type 2 diabetes mellitus.

 
  • References

  • 1 Adeshara KA, Diwan AG, Jagtap TR. et al. Relationship between plasma glycation with membrane modification, oxidative stress and expression of glucose trasporter-1 in type 2 diabetes patients with vascular complications. J Diabetes Complications 2017; 31: 439-448
  • 2 Annadurai T, Vasanthakumar A, Geraldine P. et al. Variations in erythrocyte antioxidant levels and lipid peroxidation status and in serum lipid profile parameters in relation to blood haemoglobin A1c values in individuals with type 2 diabetes mellitus. Diabetes Res Clin Pract 2014; 105: 58-69
  • 3 Zephy D, Ahmad J. Type 2 diabetes mellitus: Role of melatonin and oxidative stress. Diabetes Metab Syndr 2015; 9: 127-131
  • 4 Butkowski EG, Jelinek HF. Hyperglycaemia, oxidative stress and inflammatory markers. Redox Rep. 2017; 22: 257-264
  • 5 Pisoschi AM, Pop A. The role of antioxidants in the chemistry of oxidative stress: A review. Eur J Med Chem 2015; 97: 55-74
  • 6 Poljsak B, Šuput D, Milisav I. Achieving the balance between ROS and antioxidants: when to use the synthetic antioxidants. Oxid Med Cell Longev 2013; 2013: 956792
  • 7 Matteucci E, Giampietro O. Thiol signalling network with an eye to diabetes. Molecules 2010; 15: 8890-8903
  • 8 Turell L, Radi R, Alvarez B. The thiol pool in human plasma: the central contribution of albumin to redox processes. Free Radic Biol Med. 2013; 65: 244-253
  • 9 Erel O, Neselioglu S. A novel and automated assay for thiol/disulphide homeostasis. Clin Biochem 2014; 47: 326-332
  • 10 Kolgelier S, Ergin M, Saltuk Demir L. et al. Impaired thiol-disulfide balance in acute brucellosis. Jpn J Infect Dis 2017; 70: 258-262
  • 11 Ozler S, Oztas E, Caglar AT. et al. Thiol/disulfide homeostasis in predicting adverse perinatal outcomes at 24–28 weeks of pregnancy in gestational diabetes. J Matern Fetal Neonatal Med 2016; 29: 3699-3704
  • 12 Ergin M, Caliskanturk M, Senat A. et al. Disulfide stress in carbon monoxide poisoning. Clin Biochem 2016; 49: 1243-1247
  • 13 Ates I, Kaplan M, Inan B. et al. How does thiol/disulfide homeostasis change in prediabetic patients?. Diabetes Res Clin Pract 2015; 110: 166-171
  • 14 Ergin M, Cendek BD, Neselioglu S. et al. Dynamic thiol-disulfide homeostasis in hyperemesis gravidarum. J Perinatol. 2015; 35: 788-792
  • 15 Grindel A, Guggenberger B, Eichberger L. et al. Oxidative stress, DNA damage and DNA repair in female patients with diabetes mellitus type 2. PLoS One 2016; 11: e0162082
  • 16 Arif M, Islam MR, Waise TM. et al. DNA damage and plasma antioxidant indices in Bangladeshi type 2 diabetic patients. Diabetes Metab 2010; 36: 51-57
  • 17 Duman BS, Ozturk M, Yilmazeri S. et al. Thiols, malonaldehyde and total antioxidant status in the Turkish patients with type 2 diabetes mellitus. Tohoku J Exp Med 2003; 201: 147-155
  • 18 Piwowar A, Knapik-Kordecka M, Warwas M. Markers of oxidative protein damage in plasma and urine of type 2 diabetic patients. Br J Biomed Sci 2009; 66: 194-199
  • 19 Rani AJ, Mythili SV. Study on total antioxidant status in relation to oxidative stress in type 2 diabetes mellitus. J Clin Diagn Res 2014; 8: 108-110
  • 20 Allen EM, Mieyal JJ. Protein-thiol oxidation and cell death: regulatory role of glutaredoxins. Antioxid Redox Signal. 2012; 17: 1748-1763
  • 21 Lu SC. Glutathione synthesis. Biochim Biophys Acta. 2013; 1830: 3143-3153
  • 22 Spanidis Y, Mpesios A, Stagos D. et al. Assessment of the redox status in patients with metabolic syndrome and type 2 diabetes reveals great variations. Exp Ther Med 2016; 11: 895-903
  • 23 Sekhar RV, McKay SV, Patel SG. et al. Glutathione synthesis is diminished in patients with uncontrolled diabetes and restored by dietary supplementation with cysteine and glycine. Diabetes care 2011; 34: 162-167
  • 24 Ates I, Kaplan M, Yuksel M. et al. Determination of thiol/disulphide homeostasis in type 1 diabetes mellitus and the factors associated with thiol oxidation. Endocrine 2016; 51: 47-51
  • 25 Manna P, Jain SK. L-cysteine and hydrogen sulfide increase PIP3 and AMPK/PPARgamma expression and decrease ROS and vascular inflammation markers in high glucose treated human U937 monocytes. J Cell Biochem 2013; 114: 2334-2345
  • 26 Carter RN, Morton NM. Cysteine and hydrogen sulphide in the regulation of metabolism: insights from genetics and pharmacology. J Pathol 2016; 238: 321-332
  • 27 Hsu CC, Yen HF, Yin MC. et al. Five cysteine-containing compounds delay diabetic deterioration in Balb/cA mice. J Nutr 2004; 134: 3245-3249
  • 28 Achari AE, Jain SK. L-Cysteine supplementation increases adiponectin synthesis and secretion, and GLUT4 and glucose utilization by upregulating disulfide bond A-like protein expression mediated by MCP-1 inhibition in 3T3-L1 adipocytes exposed to high glucose. Mol Cell Biochem 2016; 414: 105-113
  • 29 Ju Y, Untereiner A, Wu L. et al. H2S-induced S-sulfhydration of pyruvate carboxylase contributes to gluconeogenesis in liver cells. Biochim Biophys Acta. (BBA)-General Subjects 2015; 1850: 2293-2303